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ABSTRACT 
Our work suggests that the forces that govern protein folding exert a profound effect on 
how genotypes are translated into phenotypes, and that this in turn has strong effects on 
evolutionary processes. Molecular chaperones, also known as “heat shock proteins” 
(Hsps), promote the correct folding and maturation of many other proteins in the cell. 
Hsp90 is an abundant and highly specialized chaperone that works on a particularly 
interesting group of client proteins: metastable signal transducers that are key regulators 
of a broad spectrum of biological processes. Such proteins often have evolved to finish 
folding only when they have received a specific signal, such as the binding of a ligand or 
a post-translational modification.  Importantly, the folding of Hsp90 clients is particularly 
sensitive to changes in the external and internal environment of the cell. Therefore, 
Hsp90 is uniquely positioned to couple environmental contingencies to the evolution of 
new traits. Our work has helped to define two mechanisms by which Hsp90 might 
influence the acquisition of new phenotypes.  First, by robustly maintaining signaling 
pathways, Hsp90 can buffer the effects of mutations in those pathways, allowing the 
storage of cryptic genetic variation that is released by stress.  In this case, when the 
Hsp90 buffer is compromised by environmental stress, new traits appear.  These traits 
can also be assimilated, so that they become manifest even in the absence of stress, when 
genetic recombination and selection enrich causative variants in subsequent generations. 
Second, Hsp90 can potentiate the effects of genetic variation, allowing new mutations to 
produce immediate phenotypes. In this case, when Hsp90 function is compromised, new 
traits are lost. These traits can also be assimilated, so that they are maintained under 
environmental stress, but this is achieved through new mutations.  We have discovered 
these powerful evolutionary mechanisms in fruit flies, mustard plants, and fungi, but 
expect them to operate in all eukaryotes.  Another line of work relating protein folding to 
the evolution of new traits involves protein-based hereditary elements known as prions.   
These produce changes in phenotype through heritable, self-perpetuating changes in 
protein conformation. Because changes in protein homeostasis occur with environmental 
stress, prions can be cured or induced by stress, creating heritable new phenotypes that 
depend upon the genetic variation present in the organism.  Both prions and Hsp90 
provide plausible mechanisms for allowing genetic diversity and fluctuating 
environments to fuel the pace of evolutionary change. The multiple mechanisms by 
which protein folding can influence the evolution of new traits provide both a new 
paradigm for understanding rapid, stepwise evolution and a framework for targeted 
therapeutic interventions. 
    Proteins are synthesized as long, linear chains of amino acids.  In order to 
function, they must fold into intricate, stereotyped, 3-dimensional structures.  Moreover, 
individual proteins must do so in a highly chaotic environment.  Inside of a living cell the 
protein concentration reaches 300 mg/ml, and those many proteins possess a tremendous 
amount of kinetic energy.  Individual proteins therefore frequently encounter folding 
problems due to macromolecular crowing.  In fact, “off-pathway” folding events are a 
constant problem.  Individual cells, and even entire organisms, live poised on the 
precipice of a protein-folding crisis, a situation that is worsened by environmental stress. 
 In the last 15 years, research in my laboratory in two different areas has pointed to 
a pivotal role for protein folding in evolutionary processes.  One of these involves the 
action of chaperone proteins, which facilitate protein folding in the complex cellular 
environment, thereby helping proteins to assume their normal functions.  The second, 
closely related line of work involves a type of hereditary element, a prion, which 
produces a change in phenotype through a heritable, self-perpetuating change in protein 
conformation.  Reflecting time constraints at this symposium, I focused my presentation 
on the role of the chaperone protein, Hsp90, and will only touch on yeast prions very 
briefly. 
 
Heat-shock proteins 
 Nearly 5% of the protein mass of the cell is devoted to helping other proteins fold 
properly and to correcting problems that occur when they misfold.  An important class of 
helper proteins (known as chaperones) is the heat-shock proteins, so-called because they 
can be induced by a shift from a normal to a slightly higher growth temperature.  We will 
concentrate here on the abundant chaperone Hsp90 and its role in facilitating the rapid 
evolution of novel traits.  Hsp90 is essential for life in eukaryotic cells.  Only small 
amounts of Hsp90 are required for growth and development under normal conditions, but 
much more is required under stressful conditions.  Unlike most chaperones it is made at 
much higher levels than it is needed, is present in excess under normal conditions, and 
therefore acts as a protein-folding buffer.  This enables it to facilitate protein folding even 
during sudden, unexpected stresses.    
Also unlike most other Hsps, Hsp90 is involved in the folding of specific 
regulatory proteins positioned strategically in major signal transduction networks, 
comprising perhaps only about 2-5% of the total protein in the cell.  Hsp90’s client 
proteins are characteristically metastable proteins that do not finish folding into their final 
stable conformations until something else has activated them, for example the binding of 
a ligand, a phosphorylation event, or translocation of the protein to the membrane. 
Protein complexes of Hsp90 with its clients are therefore extremely dynamic and strongly 
affected by stress.  Their metastable nature means that much higher concentrations of 
Hsp90 are then required to drive its client proteins into appropriate complexes.  Stressful 
conditions also cause additional cellular proteins to become unfolded (thereby creating 
additional need for Hsp90 and further depleting the buffer) Together, these properties of 
Hsp90-client interactions have a strong influence on genetic variation is translated into 
phenotypic novelty and diversity. 
   
Hsp90 buffers polymorphisms 
 The first way that Hsp90 may affect evolutionary change is by buffering genetic 
polymorphisms.  The excess Hsp90 chaperone capacity allows a variety of different 
polymorphisms throughout the genome to accumulate without phenotypic consequence.  
Within a certain range, it keeps these polymorphisms silent because it is able to maintain 
the normal folding and functioning of the signal transduction pathways controlled by its 
client proteins.  But, when stress depletes the Hsp90 buffer, phenotypes associated with 
these accumulated polymorphisms are revealed suddenly and in a combinatorial fashion. 
In this way Hsp90 acts as a “capacitor,” allowing the storage and controlled release of 
genetic variation.  This can have enormous functional consequences for the organism.  
 Our first experiments suggesting this mechanism involved some Hsp90 mutants in 
Drosophila lines that we obtained from the Rubin and Hoffmann laboratories [1].  We 
confirmed their findings that homozygotes (completely lacking Hsp90 function) died, and 
heterozygotes (with reduced Hsp90 function) were normal.  However, we noticed that a 
small number of them had astonishing, and diverse, developmental anomalies (Figure 
1a).  Interestingly, these rare developmental anomalies were generally specific to the 
genetic background into which the mutations were transferred (Figure 1b).  These 
observations suggested that reducing Hsp90 function does not just destabilize 
development; instead it reveals the effects of previously hidden genetic variation that can 
affect virtually every trait in the fly. 
 Further experiments suggested that populations of these flies contained a great 
diversity of different genetic polymorphisms. Some rare individuals exhibited several 
novel and unusual traits.  This itself was a big surprise, as most geneticists believed that 
evolution worked through small incremental mutations.  When we reduced Hsp90 
function by genetic mutation, or grew flies at a higher temperature, we observed novel 
phenotypes in those flies more frequently.  When we crossed two of the rare flies together 
and selected for that novel phenotype, we enriched subsequent generations for that 
underlying genetic variation to the point where those phenotypes were maintained – that 
is, variation was assimilated – even when Hsp90 function was normal [1].  We 
hypothesized that this interface between environmental stress and protein homeostasis 
could have a large effect on evolution. 
 We then turned to the mustard plant Arabidopsis thaliana, an inbreeding organism 
with a sessile lifestyle and considerably less heterozygosity than D. melanogaster.  We 
asked, again, what happened when Hsp90 function was reduced in different accession 
lines of Arabidopsis?  We observed a stunning array of phenotypic abnormalities that 
were specific to the individual lines:  e.g. leaves coming out in whorl shapes, plants 
growing upside-down, hairy roots, or vine-like growth (Figure 2).  We also obtained the 
same array of phenotypes by growing the plants at elevated temperatures [2, 3].  Again, 
these experiments revealed hidden genetic variation when the Hsp90 buffer was reduced 
by stress.   
 Next we examined the progeny of recombinant inbred plants from different 
ecotypes.  We studied a wide variety of normal life history traits in Arabidopsis, such as 
flowering time and number of seeds that were set.  Every single trait we studied in these 
lines had some hidden genetic variation that was exposed when Hsp90 function was 
reduced, and we were able to build a crude map of quantitative trait loci (QTL) involved 
in these traits by linkage analysis [4, 5].  This suggested that most of the underlying 
variation was genetic rather than epigenetic.  In addition to examining Hsp90 inhibition 
with chemical compounds we used RNAi inhibition, establishing that the changes in 
phenotype were absolutely due to the interface between Hsp90 and genetic variation.  
That Hsp90 has such a massive influence on the genotype-to-phenotype map in 
organisms with profoundly different lifestyles, separated by at least 1 billion years of 
evolution, suggests this mechanism has influenced evolutionary processes very broadly. 
 
Hsp90 chaperones new mutants 
 Another way that Hsp90 translates genetic variation into new phenotypes is by 
directly chaperoning mutated proteins.  Some mutations can create new activities in 
proteins, but often the mutated proteins are unable fold well on their own.  They therefore 
benefit from the Hsp90 buffer present in the cell to enable them to fold correctly into a 
functional state, and create new phenotypes.  In this way Hsp90 acts as a potentiator of 
new variation rather than as a capacitor. 
 The first class of proteins in which we observed this phenomenon was the 
oncogenic kinases such as v-Src (other kinases have the same basic phenomena).  Early 
experiments on Hsp90 were aimed at determining its basic function and that of the other 
heat-shock proteins.  At that time we had recently developed techniques to reduce Hsp90 
levels in yeast, and we introduced v-Src into those cells to model Hsp90’s effects on the 
protein.  Several different laboratories had found that oncogenic kinases were inactive 
when complexed with Hsp90, leading to speculation that it was a “protein repressor.”  
We found small differences in levels of v-Src accumulation in cells with high vs. low 
levels of Hsp90, but the activity of v-Src in the two cell types was profoundly different 
[6] (Figure 3).  Surprisingly, rather than being repressed, v-Src activity was much higher 
in the cells with high levels of Hsp90.  In contrast, cells with low levels of Hsp90 were 
able to grow normally, but unable to functionally mature the mutated, dysregulated v-Src 
kinase [7].  We also found that Hsp90 levels do not make nearly as much difference to 
the activity of c-Src, a non-mutated and much less active form of the kinase.  This 
observation has held true for a host of oncogenic kinases and been extended to several 
other types of oncogenes as well.  Indeed, studies are underway that suggest that reducing 
Hsp90 function may offer great promise as a novel therapeutic strategy for treating 
cancer [8-10].   
 In any case these studies suggested that the excess chaperone activity of Hsp90 is 
a latent reservoir that can be employed to fold newly mutated proteins and provide new 
functions.  If such mutations are ever beneficial to the organism they too could enhance 
the rate of evolution. 
 
Hsp90 Chaperones Responders 
 A related way that Hsp90 affects evolutionary novelty is by chaperoning proteins 
that respond to mutations.  Mutations that confer selective advantages in a new 
environment might not be advantageous overall because they can simultaneously create 
other problems. However, the abundant reservoir of Hsp90 can solve this dilemma 
because it chaperones a host of signal transducers that ameliorate negative effects arising 
from the mutated protein.  We first observed this phenomenon in the evolution of anti-
fungal drug resistance.  The yeast S. cerevisiae is very adept at evolving resistance when 
treated with fluconazole, a widely used triazole antifungal agent.  But, if Hsp90 activity is 
reduced pharmacologically or genetically in these cells, their ability to evolve resistance 
is greatly reduced [11].  In this case Hsp90 was not folding the mutant protein.  The 
mutation was in Erg3, which binds the azole, and the mutations simply eliminated the 
protein.  But Erg3 is involved in sterol synthesis.  When it is missing cells would 
normally die.  They survive only because the reservoir of Hsp90 is available to direct 
massive maturation of calcineurin (an Hsp90 client) [11-14], which drives many 
protective changes.   
 We then tested our hypothesis in a real-time evolution experiment.  We obtained a 
series of Candida albicans isolates from immunocompromised human patients over the 
course of 2 years of treatment (gift of Ted White, Spencer Redding and colleagues).  
Their genetic analysis had revealed that these patients were not being re-infected with a 
new strain of the pathogen. Rather, a single strain that had already infected them simply 
kept re-blooming.  We analyzed these in vivo isolates and we found that even the first 
isolates were resistant to fluconazole, in comparison to our laboratory strain, and that the 
level of resistance increased over time.  When we added small amounts of geldanamycin 
(GdA), an Hsp90 inhibitor, we found that it largely eliminated the isolates’ fluconazole 
resistance (Figure 4) [11].  That is, in this natural evolution setting all of the mutant cells 
that had acquired drug resistances depended on Hsp90 for survival.   
 We observed that in late stages of infection some of the isolates had also evolved 
resistance to fluconazole that was maintained even with GdA.  But these fungi had never 
been exposed to Hsp90 inhibitors in the patient.  What drove the assimilation of the trait?  
New mutations that made resistance independent of Hsp90.  We hypothesize that this is 
due to fever, because even a simple increase in growing temperature to 39oC phenocopied 
the specific effects of Hsp90 inhibition [11].  Indeed fevers may generally exist to 
compromise an invading pathogen’s ability to evolve resistance. 
 We have also shown that in Aspergillus, a major human pathogen that is separated 
from C. albicans by one billion years of evolution, resistance to a completely different 
class of antifungal drugs (the echinocandins) also depends on Hsp90 [11].  These 
experiments demonstrate that Hsp90-mediated mechanisms for acquiring drug resistance 
are very broadly employed by diverse human pathogens  
 
Identification of Genetic Polymorphisms Affected by Hsp90 
 To get a sense of how widespread Hsp90-dependent genetic variation can be, we 
have now exposed 96 diverse yeast strains from many ecological niches to different 
growth conditions.  This created a wide variety of phenotypes that were readily assayed 
in the lab.  We compared the growth of those cells with and without subjecting them to 
modest Hsp90 inhibition.  We found that Hsp90 inhibition can both uncover and mask 
traits in a manner that depends on genetic background.  Every trait we studied was 
affected in at least some of the strains we tested (D. Jarosz, unpublished observations).  
These experiments provide evidence for widespread naturally occurring genetic variation, 
upon which Hsp90 can act.  They also establish that Hsp90 acts on this variation both as a 
potentiator and as a capacitor, and most importantly that the effects were as often 
beneficial as detrimental.   
 To determine the nature of the genetic polymorphisms affected by Hsp90 and how 
they work, we took advantage of work of Kruglyak and colleagues, who mated very 
divergent sequenced strains of yeast to obtain meiotic segregants.  They then mapped the 
genomes of more than 100 of these segregants and with Schreiber and Perlstein [15, 16] 
identified genotypes that affected growth in the presence of many small molecules. We 
took advantage of this earlier work to map genetic variation associated with individual 
Hsp90-dependent traits.  We exposed segregants from this cross to a variety of different 
small-molecule perturbations: several from the previous work and many new ones, along 
with alternative carbon sources and DNA damaging agents.  
 In parallel, we added an Hsp90 inhibitor (radicicol) at low levels to these meiotic 
segregants to reduce the Hsp90 buffer in each growth condition (Figure 5).  We found 
that some strains gained an ability to grow and some strains lost that ability. This 
correlated with specific changes in genotype; radicicol on its own did not generally affect 
growth.  If we instead stressed the cells by growing them at a higher temperature, a 
concomitant reduction in the Hsp90 buffer had similar effect on growth.  We compiled 
the responses of these meiotic segregants across 100 different conditions and observed 
that these organisms are harboring a tremendous amount of variation that depends on 
Hsp90 for its phenotypic manifestation.  After mapping these traits to specific places in 
the genome, we identified several polymorphisms that are affected by Hsp90 by 
performing allele replacements across the entire chromosome region implicated by the 
genetic analysis.  Importantly, they were remarkably diverse in character, and included 
polymorphisms in cis-regulatory sequences, not only in coding regions.  This again 
reflects Hsp90’s influence on the folding of a wide variety of signal transducers.   
 Remarkably, these observations provide a plausible mechanism for understanding 
the rapid evolution of complex traits, and suggest that that evolution can be driven in 
unexpected ways by exposure to certain environmental stresses.  Moreover, 
understanding these evolutionary processes will help us guide new therapeutic strategies 
for cancer [8-10] and infectious disease [17, 18]. 
 
Prions 
 Not only have we shown that Hsp90 and environmental stress influence the 
interface between genotype and phenotype, but we have also found a completely different 
way in which protein folding affects this interface:  prions [19].  Prions produce a vast 
array of new heritable phenotypes through a heritable, self-perpetuating change in protein 
conformation.  I will illustrate for just one of these elements, [PSI+]. 
 The [PSI+] prion is formed from an inactive, misfolded translation-termination 
factor, Sup35, which is a self-templating amyloid.  The misfolded proteins are passed 
from mother cell to daughter and act as “seeds” to perpetuate the alternately folded prion 
state from generation to generation.  This results in the heritable read-through of stop 
codons throughout the genome.  We asked what the general consequences of [PSI+] 
might be on yeast biology, by testing seven isogenic [PSI+]/[psi-] strains for growth 
under ~200 conditions [20].  Remarkably, in each genetic background, [PSI+] produced a 
completely different constellation of phenotypes.  Thus, [PSI+] rapidly uncovers 
previously hidden genetic variation in a stepwise fashion.  Presumably, it does so by 
reactivating genes previously inactivated by stop-codon mutations, by ribosomal frame-
shifting [21], by uncovering cryptic coding potential in the 3’ untranslated regions of 
already active genes, and by changing the half-lives of messages through well-known 
mechanisms.   
 We recently devised high-throughput methods to scan the entire yeast genome 
and detect additional candidate prion-coding sequences, identifying about 200.  We tested 
the top 100 candidates for hallmarks of prion activity: ability to form amyloids, 
heritability and infectivity, and ability to alter their functional state when their 
conformational state changes.   Applying our set of assays, we found 24 prion candidates 
that satisfactorily met these criteria. Included in that number were all four of the known 
yeast prions as well as new prions involved in functions as diverse as cell wall structure 
and carbon metabolism [22].  
 Evolutionary change is fueled by genetic diversity and fluctuating environments.  
The [PSI+] prion allows cells to express diverse phenotypes in a heritable manner with no 
change in the genome.  It provides a route for selection to act on genetic variants that 
normally have no phenotypic consequence and fix them through the reversion of stop 
codons.  This would allow maintenance of the trait when cells return to the normal [psi-] 
state.  When yeast cells are stressed, switching between the prion and non-prion states 
occurs at a higher rate [23], which may give the yeast a better chance to adapt to 
challenging conditions. Thus the link between prion biology, protein folding, and 
environmental stress seems to create a “bet-hedging” strategy. Just as with alterations in 
the Hsp90 buffer, the new phenotypes that arise due to prion switching are sometimes 
beneficial and sometimes detrimental.  If a few cells (1 in 10,000 to 1 in 100,000) in the 
population switch to a detrimental state it wouldn’t matter very much for survival of the 
population.  But if the traits are beneficial they could matter a great deal.  Our work 
opens several new avenues of study, including the application of similar strategies to find 
additional prions in yeast, thorough investigation of these prions in vivo and in vitro, and 
scanning of other organisms’ genomes for prion candidates.   
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Figure Legends 
 
Figure 1.  Examples of developmental abnormalities associated with Hsp90 deficits in 
Drosophila.  (A) Thickened wing veins, (B) transformed 2nd leg with an ectopic sex 
comb, (C) deformed eye with an extra antenna, (D) disorganized abdominal tergites, (E) 
notched wings, (F) extraneous tissue growing out of tracheal pit (Reprinted from 
Rutherford and Lindquist, Nature 1998). 
 
Figure 2.  Maturation and activity of the mutated tyrosine kinase, v-Src, depends on 
hsp90.   (A) V-src accumulates at the same rate when hsp90 is inhibited, but its activity is 
reduced.  (B) C-src is much less active in general than v-src, and its activity is much less 
dependent on hsp90 levels. 
 
Figure 3.  The importance of Hsp90 in fluconazole (FL) resistance in C. albicans. FL 
resistance of clinical isolates was initially Hsp90-dependent but evolved toward 
independence. Left, FL sensitivity of CAI4 and resistance of serial clinical specimens 
(CaCi) isolated from an HIV patient receiving FL; isolates are ordered sequentially, with 
those recovered early at the top. Middle, inhibition of Hsp90 by GdA (5 mM).  Right, 
elevated temperatures reduce FL resistance of CaCi isolates.  (Reprinted from Cowen and 
Lindquist, Science 2005). 
 Figure 4.  The same recombinant inbred line (RIL)-specific phenotypes are uncovered 
when Hsp90 buffering capacity is challenged by GDA (top) or by growth at 27 C 
(bottom). Line 082 seedlings, S-shaped rosettes with vertically oriented leaf blades. Line 
113 seedlings, extreme hypocotyl curls and roots partially extended into air. Line 104 
seedlings, abundant root hair growth. Line 134 seedlings, bent hypocotyls with rosette 
touching the medium surface. (Reprinted from Queitsch et al., Nature 2002) 
 
 
Figure 5.  Examples of phenotypic transitions elicited in S. cerevisiae by reducing the 
Hsp90 buffer.  Genotyped meiotic segregants from a cross between two sequenced 
genetic backgrounds are arrayed in 384-well plates and their growth was monitored 
across a broad array of conditions and in parallel when reducing the Hsp90 buffer. In 
some conditions growth is enhanced when the Hsp90 buffer is reduced, and this occurs in 
segregants with shared genetic polymorphisms. Growth can also be reduced when Hsp90 
is inhibited.  Again, the response occurs in segregants that share certain regions of their 
genomes. 
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